What is InspireMD Inc (NSPR) stock price today?

InspireMD Inc (NSPR) currently trades at $1.18 per share. The stock has a market capitalization of $56.63M and a P/E ratio of —x.

Is NSPR stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, InspireMD Inc has a Smart Value Score of 36/100 (Grade D), resulting in a "Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

What is InspireMD Inc's revenue and earnings?

InspireMD Inc has trailing twelve-month (TTM) revenue of $8.98M with profit margins of 0.00%. Earnings per share (EPS) is $-0.76.

Is NSPR stock overvalued or undervalued?

Based on our DCF model, InspireMD Inc's intrinsic value is $2.87, representing a margin of safety of 39.90%. The stock currently trades at a P/E of —x.

NSPR

InspireMD Inc

NASDAQ: NSPR · HEALTHCARE · MEDICAL DEVICES

$1.18

+3.51% today

Updated 2026-04-30

Market cap

$56.63M

P/E ratio

—

P/S ratio

6.31x

EPS (TTM)

$-0.76

Dividend yield

—

52W range

$1 – $3

Volume

0.0M

Market cap

$56.63M

P/E ratio

—

P/S ratio

6.31x

EPS (TTM)

$-0.76

Dividend yield

—

52W range

$1 – $3

Volume

0.0M

WallStSmart proprietary scores

out of 100

Grade: D

Sell

Investment rating

8.0

Growth

5.0

Quality

C+

2.5

Profitability

6.7

Valuation

—/9

Piotroski F-Score

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →202 stocks currently score above 75

Price targets

Analyst target

$5.00

+323.73%

12-Month target

—

Intrinsic (DCF)

$2.87

Margin of safety

+39.90%

2 Strong Buy1 Buy0 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

+ Revenue growth 61.60% QoQ

+ 39.90% below intrinsic value

Risks

- Thin margins at 0.00%

- Negative free cash flow $-9.74M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$5.17M	$6.21M	$7.01M	$8.98M	$8.98M
Net income	$-18.49M	$-19.92M	$-32.01M	$-48.79M	$-11.76M
EPS	—	—	—	—	$-0.76
Free cash flow	$-16.02M	$-16.76M	$-23.27M	$-36.77M	$-9.74M
Profit margin	-357.59%	-320.97%	-456.63%	-543.33%	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
NSPR	$56.63M	36	8.0	2.5	6.7	5.0	+39.90%	Hold
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$322.34B	54	5.3	5.5	7.3	4.8	+42.06%	Buy
AZN	$294.17B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

InspireMD Inc trades at $1.18. Our Smart Value Score of 36/100 indicates the stock is weak. TTM revenue stands at $8.98M. Our DCF model estimates intrinsic value at $2.87.

Frequently asked questions

What is InspireMD Inc's stock price?

InspireMD Inc (NSPR) trades at $1.18.

Is InspireMD Inc overvalued?

Smart Value Score 36/100 (Grade D, Sell). DCF value $2.87.

What is the price target of InspireMD Inc (NSPR)?

The analyst target price is $5.00, representing +323.7% upside from the current price of $1.18.

What is the intrinsic value of InspireMD Inc (NSPR)?

Based on our DCF model, intrinsic value is $2.87, a +39.9% margin of safety versus $1.18.

What is InspireMD Inc's revenue?

TTM revenue is $8.98M.

Company info

SectorHEALTHCARE

IndustryMEDICAL DEVICES

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio6.31x

ROE-106.90%

Beta0.94

50D MA$1.59

200D MA$2.01

Shares out0.05B

Float0.03B

Short ratio—

Avg volume0.0M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

NSPR vs LLY →NSPR vs JNJ →NSPR vs ABBV →Stock screener →